Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
CC transcript
Director departure
Inv. presentation
Orexigen Therapeutics, Inc. (OREXQ) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/04/2019 4 BAUPOST GROUP LLC/MA (10% Owner) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Disposed of options to buy @ $0
Disposed of 5,000,000 options to buy @ $0
Disposed of 100,000,000 options to buy @ $0
10/31/2018 4 BAUPOST GROUP LLC/MA (10% Owner) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Sold 650,000 shares @ $0.01, valued at $6.5k
Sold 896,339 shares @ $0.01, valued at $9k
10/26/2018 4 BAUPOST GROUP LLC/MA (10% Owner) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Sold 28,000 shares @ $0.01, valued at $280
Sold 652,500 shares @ $0.01, valued at $6.5k
04/26/2018 4 BAUPOST GROUP LLC/MA (10% Owner) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Disposed of 16,483,517 options to buy @ $7.5, valued at $123.6M
03/16/2018 4 Moglia Stephen A. (VP & Chief Accounting Officer) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Sold 1,694 shares @ $0.24, valued at $406.6
10/17/2017 4 Lynch Thomas P. (EVP, Chief Admin Off, GC & Sec) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 69,600 restricted stock units @ $0
10/17/2017 4 Keyes Jason A (EVP, CFO) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 69,600 restricted stock units @ $0
10/17/2017 4 Flynn Peter D (EVP, Head of Global Dev) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 69,600 restricted stock units @ $0
10/17/2017 4 Cannell Thomas R (EVP, COO, Pres Global Com Prod) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 91,200 restricted stock units @ $0
10/17/2017 4 NARACHI MICHAEL (CEO & President) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 252,000 restricted stock units @ $0
07/18/2017 4 Zoth Lota S. (Director) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 5,000 options to buy @ $2.88, valued at $14.4k
07/18/2017 4 MAHAFFY PATRICK J (Director) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 5,000 options to buy @ $2.88, valued at $14.4k
07/18/2017 4 JORN DEBORA (Director) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 5,000 options to buy @ $2.88, valued at $14.4k
07/18/2017 4 Honig Peter (Director) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 5,000 options to buy @ $2.88, valued at $14.4k
07/18/2017 4 Endicott David J. (Director) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 5,000 options to buy @ $2.88, valued at $14.4k
07/18/2017 4 BOCK LOUIS C (Director) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 5,000 options to buy @ $2.88, valued at $14.4k
07/18/2017 4 DOVEY BRIAN H (Director) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 5,000 options to buy @ $2.88, valued at $14.4k
06/02/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/02/2017 4 Lynch Thomas P. (EVP. General Counsel & Sec.) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 1,704 shares @ $1.55, valued at $2.6k
06/02/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/02/2017 4 Cannell Thomas R (EVP, COO, Pres Global Com Prod) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 2,119 shares @ $1.55, valued at $3.3k
02/07/2017 4 NARACHI MICHAEL (CEO & President) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 315,000 options @ $4.1, valued at $1.3M
Granted 157,500 options @ $15, valued at $2.4M
02/07/2017 4 Lynch Thomas P. (EVP. General Counsel & Sec.) has filed a Form 4 on Orexigen Therapeutics, Inc.
02/07/2017 4 Keyes Jason A (SVP, CFO) has filed a Form 4 on Orexigen Therapeutics, Inc.
02/07/2017 4 Flynn Peter D (SVP, Dev, Reg Affairs, Safety) has filed a Form 4 on Orexigen Therapeutics, Inc.
02/07/2017 4 Cannell Thomas R (EVP, COO, Pres Global Com Prod) has filed a Form 4 on Orexigen Therapeutics, Inc.
12/21/2016 4 Moglia Stephen A. (VP, Chief Accounting Officer) has filed a Form 4 on Orexigen Therapeutics, Inc.
12/02/2016 4 NARACHI MICHAEL (CEO & President) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 802 shares @ $1.67, valued at $1.3k
12/02/2016 4 Keyes Jason A (SVP, CFO) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 291 shares @ $1.67, valued at $486
12/02/2016 4 Cannell Thomas R (EVP, COO, Pres Global Com Prod) has filed a Form 4 on Orexigen Therapeutics, Inc.
07/14/2016 4 Lynch Thomas P. (EVP. General Counsel & Sec.) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 131,250 options @ $4.02, valued at $527.6k
Granted 26,250 options @ $4.02, valued at $105.5k
Granted 78,750 options @ $15, valued at $1.2M
Granted 15,750 options @ $15, valued at $236.3k
07/14/2016 4 Keyes Jason A (SVP, CFO) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 131,250 options @ $4.02, valued at $527.6k
Granted 26,250 options @ $4.02, valued at $105.5k
Granted 78,750 options @ $15, valued at $1.2M
Granted 15,750 options @ $15, valued at $236.3k
07/14/2016 4 Flynn Peter D (SVP, Dev, Reg Affairs, Safety) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 131,250 options @ $4.02, valued at $527.6k
Granted 26,250 options @ $4.02, valued at $105.5k
Granted 78,750 options @ $15, valued at $1.2M
Granted 15,750 options @ $15, valued at $236.3k
07/14/2016 4 Cannell Thomas R (EVP, Chief Commercial Officer) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns: Granted 157,500 options @ $15, valued at $2.4M
Granted 31,500 options @ $15, valued at $472.5k
Granted 262,500 options @ $4.02, valued at $1.1M
Granted 52,500 options @ $4.02, valued at $211.1k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy